Safety and treatment patterns of multikinase inhibitors in patients with metastatic renal cell carcinoma at a tertiary oncology center in Italy

BACKGROUND: Multikinase inhibitors (MKIs) sunitinib and sorafenib have become a standard of care for metastatic renal cell carcinoma (mRCC). This study assessed safety and treatment patterns for these agents in a real-world clinical practice setting in Italy. METHODS: A retrospective medical record...

Full description

Saved in:
Bibliographic Details
Main Authors: Porta, Camillo, Paglino, Chiara, Imarisio, Ilaria, Canipari, Cinzia, Chen, Kristina, Neary, Maureen, Duh, Mei Sheng
Format: Artigo
Language:Inglês
Published: BioMed Central 2011
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3079688/
https://ncbi.nlm.nih.gov/pubmed/21435216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-11-105
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items